Molecular mechanism of upregulation of survivin transcription by the AT-rich DNA-binding ligand, Hoechst33342: Evidence for survivin involvement in drug resistance

Nucleic Acids Research

Volumn 35, Issue 7, 2007, Pages 2390-2402

  Wu, Jianguo ^a   Apontes, Pasha ^a   Song, Lei ^a   Liang, Ping ^b   Yang, Lily ^b   Li, Fengzhi ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR INDEPENDENCE 1; HOE 33342; LUCIFERASE; MESSENGER RNA; OLIGONUCLEOTIDE; SURVIVIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; BENZIMIDAZOLE DERIVATIVE; BIRC5 PROTEIN, HUMAN; DNA BINDING PROTEIN; LIGAND; MICROTUBULE ASSOCIATED PROTEIN; TUMOR PROTEIN;

ARTICLE; AT RICH SEQUENCE; BINDING SITE; CANCER CELL CULTURE; CANCER RESISTANCE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DNA BINDING; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN INTERACTION; TRANSCRIPTION REGULATION; UPREGULATION; BIOSYNTHESIS; CHEMISTRY; DNA FOOTPRINTING; DRUG RESISTANCE; GENETICS; METABOLISM; PHYSIOLOGY; TRANSACTIVATION; TUMOR CELL LINE;

AT RICH SEQUENCE; BENZIMIDAZOLES; BINDING SITES; CELL LINE, TUMOR; DNA FOOTPRINTING; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; HUMANS; LIGANDS; LUCIFERASES; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); UP-REGULATION;

EID: 34249859755     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkm149     Document Type: Article

References (27)

1. Deveraux,Q.L. and Reed,J.C. (1999) IAP family proteins - suppressors of apoptosis. Genes Dev., 13, 239-252.
2. Liston,P., Fong,W.G. and Korneluk,R.G. (2003) The inhibitors of apoptosis: There is more to life than Bcl2. Oncogene, 22, 8568-8580.
3. Salvesen,G.S. and Duckett,C.S. (2002) IAP proteins: Blocking the road to death's door. Nat. Rev. Mol. Cell. Biol., 3, 401-410.
4. Li,F. (2003) Survivin study: What is the next wave? J. Cell. Physiol. 197, 8-29.
5. Altieri,D.C. (2003) Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene, 22, 8581-8589.
6. Li,F. and Ling,X. (2006) Survivin study: An update of "What is the next wave?" J. Cell. Physiol., 208, 476-486.
7. Li,F. (2005) Role of survivin and its splice variants in tumorigenesis. Br. J. Cancer, 92, 212-216.
8. Wu,J., Ling,X., Pan,D., Apontes,P., Song,L., Liang,P., Altieri,D.C., Beerman,T. and Li,F. (2005) Molecular mechanism of inhibition of survivin transcription by the GC-rich sequence selective DNA-binding antitumor agent, hedamycin: Evidence of survivin downregulation associated with drug sensitivity. J. Biol. Chem., 280, 9745-9751.
9. Ling,X., Bernacki,R.J., Brattain,M.G. and Li,F. (2004) Induction of survivin expression by taxol (paclitaxel) is an early event which is independent on taxol-mediated G2/M arrest. J. Biol. Chem., 279 15196-15203.
10. Li,F., Ling,X., Huang,H., Brattain,L., Apontes,P., Wu,J., Binderup,L. and Brattain,M.G. (2005) Differential regulation of survivin expression and apoptosis by vitamin D(3) compounds in two isogenic MCF-7 breast cancer cell sublines. Oncogene, 24, 1385-1395.
11. Li,F. and Altieri,D.C. (1999) Transcriptional analysis of human survivin gene expression. Biochem. J., 344(Pt 2), 305-311.
12. Ling,X., Yang,J., Tan,D., Ramnath,N., Younis,T., Bundy,B.N., Slocum,H.K., Yang,L., Zhou,M. et al. (2005) Differential expression of survivin-2B and survivin-DeltaEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC). Lung Cancer, 49, 353-361.
13. Ghadersohi,A., Pan,D., Fayazi,Z., Hicks,D.G., Winston,J.S. and Li,F. (2006) Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo. Breast Cancer Res. Treat., 102, 19-30 (Aug 8, Epub ahead of hard copy).
14. Li,F., Ambrosini,G., Chu,E.Y., Plescia,J., Tognin,S., Marchisio,P.C. and Altieri,D.C. (1998) Control of apoptosis and mitotic spindle checkpoint by survivin. Nature, 396, 580-584.
15. Ling,X. and Li,F. (2004) Silencing of antiapoptotic survivin gene by multiple approaches of RNA interference technology. Bio Techniques 36, 450-454, 456-460.
16. Duan,Z. and Horwitz,M. (2003) Targets of the transcriptional repressor oncoprotein Gfi-1. Proc. Natl Acad Sci. USA, 100, 5932-5937.
17. Portugal,J. and Waring,M.J. (1988) Assignment of DNA binding sites for 4′,6-diamidine-2-phenylindole and bisbenzimide (Hoechst 33258). A comparative footprinting study. Biochim. Biophys. Acta, 949, 158-168.
18. Schmid,M., Feichtinger,W., Deubelbeiss,C. and Weller,E. (1987) The fragile site (17)(p12): Induction by AT-specific DNA-ligands and population cytogenetics. Hum. Genet., 77, 118-121.
19. Li,F. (2005) Survivin, other IAPs, Smac/DIABLO, and Omi/HtrA2 - modulation of the advancing apoptotic process. In Los,M. and Gibson,S.B. (eds), "Apoptotic pathways as target for novel therapies in cancer and other diseases". Kluwer Press, New York, (ISBN: 0-387-23384-9), pp. 137-155.
20. Zhang,M., Yang,J. and Li,F. (2006) Transcriptional and post-transcriptional controls of survivin in cancer cells: Novel approaches for cancer treatment. J. Exp. Clin. Cancer Res., 25 391-402.
21. Spaulding,B., Pan,D., Ghadersohi,A., Nielsen,G., Jensen,S., Gellert,F., Ling,X, Zhang,M., Black,A. et al. (2006) Characterization of the 12C4 survivin monoclonal antibody and insight into the expression of survivin in human adult tissues. Histopathology, 49, 622-633.
22. Hock,H., Hamblen,M.J, Rooke,H.M., Schindler,J.W., Saleque,S., Fujiwara,Y. and Orldn,S.H. (2004) Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Nature 431, 1002-1007.
23. Zeng,H., Yucel,R., Kosan,C., Klein-Hitpass,L. and Moroy,T. (2004) Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells. EMBO J., 23, 4116-4125.
24. Moroy,T. (2005) The zinc finger transcription factor Growth factor independence 1 (Gfil). Int. J. Biochem. Cell. Biol., 37, 541-546.
25. Zhang,X. and Kiechle,F.L. (1998) Hoechst 33342 induces apoptosis and alters tata box binding protein/DNA complexes in nuclei from BC3H-1 myocytes. Biochem. Biophys. Res. Commun., 248, 18-21.
26. Zhang,X. and Kiechle,F.L. (2001) Hoechst 33342-induced apoptosis is associated with intracellular accumulation of E2F-1 protein in BC3H-1 myocytes and HL-60 cells. Arch. Pathol. Lab. Med., 125, 99-104.
27. Koo,T.H., Lee,J.J., Kim,E.M., Kim,K.W., Kim,H.D. and Lee,J.H. (2002) Syntenin is overexpressed and promotes cell migration in metastatic human breast and gastric cancer cell lines. Oncogene, 21, 4080-4088.